Skip to main content
. 2015 May 18;53(2):101–105. doi: 10.5114/reum.2015.51510

Table I.

Myositis-specific antibodies, acc. to [17]

Myositis-specific antibodies Autoantibody frequency
Anti-synthetase antibodies 30–40%
Anti-Jo-1 anti-histidyl-tRNA synthetase most common (about 20% of idiopathic inflammatory myopathies)
 PL 12 anti-alanyl-tRNA synthetase
 PL 7 anti-threonyl-tRNA synthetase
 EJ anti-glycyl-tRNA synthetase
 OJ anti-isoleucyl-tRNA synthetase
 KS anti-asparaginyl-tRNA synthetase
 Zo anti-phenylalanyl-tRNA synthetase
 Ha anti-tyrosyl-tRNA synthetase
Mi-2 (anti-nuclear ATPase/helicase) < 10%
SRP signal recognition particle – anti-ribonucleoprotein (proteins 7SLRNA) 5%
Anti-TIF1-γ (anti-p155/140 autoantibodies) 13–21%
Anti-MDA-5 (cytoplasmic protein melanoma differentiation-associated gene 5 unknown
NXP-2 (nuclear matrix protein) unknown
Anti-SAE (anti-small ubiquitin-like modifier activating enzyme) 5%